Results 171 to 180 of about 3,371,263 (384)
Repurposing the Antipsychotic Trifluoperazine as an Antimetastasis Agent [PDF]
Ashleigh Pulkoski‐Gross +7 more
openalex +1 more source
ABSTRACT Background Guidelines for managing acute behavioural disturbance typically exclusively focus on care for adults in mental health and related settings, how this should be adapted to safely manage in pregnancy and the early postpartum including in settings such as maternity wards is less clear. Aims To undertake a systematic and state of the art
Megan Galbally +6 more
wiley +1 more source
Benzisoxazole- and Benzisothiazole-3-carboxamides as Potential Atypical Antipsychotic Agents
Nicholas J. Hrib +7 more
openalex +1 more source
ABSTRACT Background People with intellectual disabilities face significant health disparities and often encounter barriers in accessing healthcare services. Although research supports the need for reasonable adjustments to improve healthcare access for this population, implementation in acute healthcare settings remains limited.
Owen Doody +5 more
wiley +1 more source
Antipsychotic agents deteriorate brain and retinal function in schizophrenia patients with combined auditory and visual hallucinations: A pilot study and secondary follow-up study. [PDF]
Zhuo C +10 more
europepmc +1 more source
Flow and Microwave Induced Pellizzari Reactions: Synthesis of Heterocyclic Analogues of the Benzoxazepine Antipsychotic Agents Loxapine and JL-13 [PDF]
Nadeesha Ranasinghe +8 more
openalex +1 more source
ABSTRACT Background Research suggests people with a learning disability experience high prevalence of adverse life events which may result in trauma‐related mental health conditions. Identifying trauma‐related mental health conditions can facilitate access to support, however research suggests they may be under‐identified in this group. The aim of this
Sarah Wigham +7 more
wiley +1 more source
Use of second-generation antipsychotic agents for sleep and sedation: a provider survey.
Eric D A Hermes +2 more
semanticscholar +1 more source
Preclinical models for evaluating psychedelics in the treatment of major depressive disorder
Psychedelic drugs have seen a resurgence in interest as a next generation of psychiatric medicines with potential as rapid‐acting antidepressants (RAADs). Despite promising early clinical trials, the mechanisms which underlie the effects of psychedelics are poorly understood.
Laith Alexander +5 more
wiley +1 more source

